Barcelona, Spain

Jorge Medrano Rupérez


 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010-2019

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Jorge Medrano Rupérez: Innovator in Pharmaceutical Chemistry

Introduction

Jorge Medrano Rupérez is a noteworthy inventor based in Barcelona, Spain. He holds a significant portfolio of seven patents focused on advancements in pharmaceutical chemistry. His innovative work primarily revolves around polymorphs and solvates of hydrochloride salts, contributing to the development of pharmaceutical compositions.

Latest Patents

Among his latest patents is the invention of "4-[-2-[[5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates." This patent outlines processes for preparing various polymorphs and solvates of the hydrochloride salt of 4-[2-[[5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine (P027), emphasizing their potential pharmaceutical applications.

Career Highlights

Jorge's career is marked by his work with esteemed companies such as Esteve Química S.A. and Laboratories Del Dr. Esteve S.A. His contributions to these organizations reflect his expertise in pharmaceutical research and development, focusing on creating effective therapeutic solutions.

Collaborations

Throughout his career, Jorge has collaborated with notable professionals in the field, including Ramón Berenguer Maimó and Laura Coppi. These collaborations have enabled him to enhance his research, paving the way for innovative solutions in the pharmaceutical industry.

Conclusion

Jorge Medrano Rupérez stands out as a brilliant inventor in the realm of pharmaceutical chemistry. With multiple patents and significant industry collaborations, his work continues to make a meaningful impact on medicinal science and drug development. His innovative spirit and dedication to enhancing pharmaceutical formulations are commendable, as they contribute to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…